oninvasive detection of circulating tumor DNA for disease classification and monitoring in patients with brain tumors.
Recruiting
- Conditions
- C71C72Malignant neoplasm of brainMalignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system
- Registration Number
- DRKS00015307
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients with suspected brain cancer or diagnosed with brain cancer
Exclusion Criteria
None
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PFS difference based on ctDNA positivity after initial treatment, measured by sequencing methods
- Secondary Outcome Measures
Name Time Method OS difference based on ctDNA positivity after initial treatment, measured by sequencing methods